Navigation Links
Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos
Date:10/18/2007

first time both high accuracy and efficiency in embryonic chromosomal analysis with rapid assessment in a clinically-useful time frame."

In this new process, a single cell is removed from an embryo on the third day of embryonic development. The 3 billion base-pairs of nucleic acid that make up a single copy of human DNA weigh only 6 trillionths of a gram, which is too small to allow analysis. It is necessary first to copy this code over one million times with great fidelity to accumulate sufficient DNA to accurately analyze the number of chromosomes present in the cell. This step, termed whole genomic amplification (WGA), one of many technologically demanding steps required for this process, has been refined extensively by the team at RMA. Once amplified, approximately 250,000 different areas of the DNA, called single nucleotide polymorphisms (SNPs, or "snips") are individually examined and assigned a specific copy number. These copy numbers are then collated for each chromosome and the number of each individual chromosome calculated.

This process makes it possible to identify any deviation from the normal copy number of two for each chromosome pair in a developing embryo. Copy numbers of "one" or "three or more" indicate a chromosomally-abnormal embryo which would generally not implant but which may implant and lead to subsequent miscarriage or, rarely, result in the birth of an anomalous child. This technology should improve delivery rates of healthy children for some couples who are infertile or who experience recurrent miscarriage.

About RMA

Reproductive Medicine Associates (RMA) of New Jersey is one of the world's leading centers for treatment and research in reproductive medicine. RMA's founding partners and physicians have helped bring more than 17,000 babies to loving parents. RMA is also world-renowned for having one of the highest success rates in the treatment of infertility.


'/>"/>
SOURCE Reproductive Medicine Associates of New Jersey
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Researchers Discover Gene For Rare Skin Disorder
5. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
9. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
10. Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
11. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...sults demonstrating that TYKERB and trastuzumab to...on of progression-free survival (PFS), -- Combini...e and,outside of the HER2 receptor may create a mo...activity of TYKERB alone despite patients,previou... chemotherapy, LONDON and PHILADELPHIA, May 16 /P...
(Date:5/16/2008)...tically Significant Reductions in Selected ...to be published in 2008 Proceedings of the America...cology, SAN DIEGO, May 16 /PRNewswire-FirstCall/ ...nounced today that, in a registrational bioequival...tically significant reduction,in general disorders...
(Date:5/15/2008)...ta highlight safety profile of BSI-201 in ...ISBANE, Calif., May 15 /- BiPar Scien...any developing novel cancer therapies,today annou... BSI-201, will,be presented at the 2008 American S...ago., Findings will be presented from the first i...
(Date:5/15/2008)...RNewswire-FirstCall/ -- Schering-Plough,Corporatio... and treatment of,chronic hepatitis C virus (HCV) ...clinical studies with PEGINTRON(TM) (peginterferon...ion therapy, as well as boceprevir, the,company,s ...be presented at,the 39th annual Digestive Disease ...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 2ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 3ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 4ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study 5BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 2Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 3Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 4Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 5Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 6Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting 7Baltimore Washington Medical Center Hosts Day of Dance for Health 10732 1Baltimore Washington Medical Center Hosts Day of Dance for Health 10732 2Study finds widespread vitamin and mineral use among cancer survivors 10729 1Study finds widespread vitamin and mineral use among cancer survivors 10729 2Unilens Vision Inc Declares Regular Quarterly Cash Dividend of U S 240 09 Per Share 10722 1Unilens Vision Inc Declares Regular Quarterly Cash Dividend of U S 240 09 Per Share 10722 2Unintended Errors Leave Many Newborns Vulnerable 10721 1Unintended Errors Leave Many Newborns Vulnerable 10721 2
...Genex Technologies,Inc. announced today data from ...n with docetaxel in patients with metastatic breas... Cancer Institute,of Canada - Clinical Trials Grou...2007 Annual Meeting in Los Angeles, Calif. , , ...ients treated, five patients (33.3 percent) showed...
...esearchers from the,Barbara Ann Karmanos Cancer In...oday that an antibiotic typically prescribed for,A...ly treating,certain types of cancers. , Q. Ping Do...and,members of his lab announced the findings of t...ppears to have an anti-tumor effect,in mice bearin...
Other Medicine Technology:OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 2OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 3OncoGenex Technologies Announces Phase II Data of OGX-011 in,Metastatic Breast Cancer at American Association for Cancer,Research 2007 Annual Meeting 4Alzheimer's Drug Shows Promise in Fighting Cancer 2
(Date:5/16/2008)... AIDS Vaccine is Possible and,Still Urgently Neede...Twenty-five years since the,discovery of HIV, the ...,the AIDS pandemic. Scientists have learned a trem...er pathogen, and have developed more drugs to,trea... this progress is not,enough. While it is vital to...
(Date:5/16/2008)...ewswire/ -- Less than a week after,committing medi...tated by,Cyclone Nargis, Project HOPE, an internat... organization, is again mobilizing its full,resour...r the people of,central China devastated by the ma...ves., "I am saddened by the vast loss of life and...
(Date:5/16/2008)... abstracts or poster presentations at the annual m...y (ASCO) to be held in Chicago, Illinois, May 30 ...arly Detection of Malignant Pleural Mesothelioma ...ly detection and prognostic marker,in malignant p... Pass, M.D., professor of cardiothoracic surgery a...
(Date:5/16/2008)...wire/ -- Behavioral healthcare,systems are playing...llions,of Americans of all ages who experience psy...ccording to the latest annual survey from the,Nati...PHS) released today., The 2007 NAPHS Annual Surve...care delivery. One chapter provides a trend analys...
Breaking Medicine News(10 mins):Health News:World AIDS Vaccine Day 2008 2Health News:World AIDS Vaccine Day 2008 3Health News:World AIDS Vaccine Day 2008 4Health News:Project HOPE to Send Humanitarian Assistance to China as Humanitarian Assistance to Myanmar Continues 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 2Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 3Health News:NYU Langone Medical Center's tip sheet to the 44th annual meeting of ASCO 4Health News:New NAPHS Annual Survey Tracks Behavioral Treatment Trends 2
...chers are conducting a study to find out ways to i...eople. // Pfizer Australia Cardio Vascular Lipid (...r Clair Sullivan from the Centre for Diabetes and ... Queensland and Princess Alexandra Hospital for th...
...t difference found with respect to major clinical ...ng C-section. Some women, however had lower blood...ral anesthesia and some experienced more nausea an...This was the first such review to consider both ne...
...main culprit for nerve fibre damage in multiple sc...ne system, which is vital for early diagnosis // a.... The study indicated the manner in which immune s...tacks by hampering the energy production in nerve ...
...emonstrated how intense struggle among the human i...us to survive harm and take on a more virulent for... The study, which uses a computer model of simulta...es a hint of a new strategy for using vaccines aga...
Other Medicine News:Health News:Choice of Anesthesia in C-section 2Health News:Choice of Anesthesia in C-section 3Health News:Basis for Nerve fiber Damage in Multiple Sclerosis Discovered 2Health News:Basis for Nerve fiber Damage in Multiple Sclerosis Discovered 3Health News:HIV Takes Advantage of Rivalry among T cells 2Health News:HIV Takes Advantage of Rivalry among T cells 3
The Shandon Manual Staining Station is ideal for special processes, frozen sections, special stains and low volume procedures.
The Shandon Finesse 315 low-cost precision microtome is ergonomically designed to consistently produce high quality routine paraffin sections without user strain or fatigue.
The new Shandon HistocentreTM 3 is an integral part of the workflow in Histology laboratories, representing a workstation that complements any automatic tissue processor.
Shandon HistoWave is the answer to rapid tissue processing. It reduces time for fixation, tissue processing, decalification, immunochemistry and special stains.
Medicine Products: